Clinical Trial Update: Safety and Efficacy of Eribullin or Eribulin Combined With Anlotinib in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of eribulin combined with anlotinib in metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Anlotinib (anlotinib)
• eribullin (eribulin)

Snippet

Sponsor: Hunan Cancer Hospital | Conditions: Metastatic Breast Cancer | Phase 2 | Status: COMPLETED